Global CNS Specific Antisense Oligonucleotides Supply, Demand and Key Producers, 2023-2029

Page: 102

Published Date: 31 Jan 2023

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global CNS Specific Antisense Oligonucleotides market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Antisense oligonucleotides are single-stranded oligodeoxynucleotides that can alter the RNA and modify protein expression. These oligonucleotides were discovered to influence RNA processing. Subsequent chemical modifications of antisense oligonucleotides were used to address issues such as off-target toxic effects and insufficient biological activity. These modifications led to an improved mechanism of antisense oligonucleotides and clinical trial design. This paved the way toward translating their use into therapies for various genetic and neurological conditions. Antisense oligonucleotides mediated therapies target the source of pathogenesis and have higher chance of success as compared to therapies that target downstream pathways. These are drugs for the treatment of central nervous system (CNS) disorders, as they have specific molecular targeting and extended pharmacological properties.

This report studies the global CNS Specific Antisense Oligonucleotides demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for CNS Specific Antisense Oligonucleotides, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of CNS Specific Antisense Oligonucleotides that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global CNS Specific Antisense Oligonucleotides total market, 2018-2029, (USD Million)
Global CNS Specific Antisense Oligonucleotides total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: CNS Specific Antisense Oligonucleotides total market, key domestic companies and share, (USD Million)
Global CNS Specific Antisense Oligonucleotides revenue by player and market share 2018-2023, (USD Million)
Global CNS Specific Antisense Oligonucleotides total market by Type, CAGR, 2018-2029, (USD Million)
Global CNS Specific Antisense Oligonucleotides total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global CNS Specific Antisense Oligonucleotides market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Akcea Therapeutics, Inc., Ionis Pharmaceuticals Inc., Biogen Inc., Sarepta Therapeutics, Wave Life Sciences Ltd., Dynacure, ProQR Therapeutics N.V. and Stroke Therapeutic Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CNS Specific Antisense Oligonucleotides market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global CNS Specific Antisense Oligonucleotides Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global CNS Specific Antisense Oligonucleotides Market, Segmentation by Type
Polyneuropathy Treatment
Spinal Muscular Atrophy (SMA) Treatment
Huntington’s Disease Treatment

Global CNS Specific Antisense Oligonucleotides Market, Segmentation by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Companies Profiled:
Akcea Therapeutics, Inc.
Ionis Pharmaceuticals Inc.
Biogen Inc.
Sarepta Therapeutics
Wave Life Sciences Ltd.
Dynacure
ProQR Therapeutics N.V.
Stroke Therapeutic Inc.

Key Questions Answered
1. How big is the global CNS Specific Antisense Oligonucleotides market?
2. What is the demand of the global CNS Specific Antisense Oligonucleotides market?
3. What is the year over year growth of the global CNS Specific Antisense Oligonucleotides market?
4. What is the total value of the global CNS Specific Antisense Oligonucleotides market?
5. Who are the major players in the global CNS Specific Antisense Oligonucleotides market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 CNS Specific Antisense Oligonucleotides Introduction
    1.2 World CNS Specific Antisense Oligonucleotides Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World CNS Specific Antisense Oligonucleotides Total Market by Region (by Headquarter Location)
        1.3.1 World CNS Specific Antisense Oligonucleotides Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States CNS Specific Antisense Oligonucleotides Market Size (2018-2029)
        1.3.3 China CNS Specific Antisense Oligonucleotides Market Size (2018-2029)
        1.3.4 Europe CNS Specific Antisense Oligonucleotides Market Size (2018-2029)
        1.3.5 Japan CNS Specific Antisense Oligonucleotides Market Size (2018-2029)
        1.3.6 South Korea CNS Specific Antisense Oligonucleotides Market Size (2018-2029)
        1.3.7 ASEAN CNS Specific Antisense Oligonucleotides Market Size (2018-2029)
        1.3.8 India CNS Specific Antisense Oligonucleotides Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 CNS Specific Antisense Oligonucleotides Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 CNS Specific Antisense Oligonucleotides Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World CNS Specific Antisense Oligonucleotides Consumption Value (2018-2029)
    2.2 World CNS Specific Antisense Oligonucleotides Consumption Value by Region
        2.2.1 World CNS Specific Antisense Oligonucleotides Consumption Value by Region (2018-2023)
        2.2.2 World CNS Specific Antisense Oligonucleotides Consumption Value Forecast by Region (2024-2029)
    2.3 United States CNS Specific Antisense Oligonucleotides Consumption Value (2018-2029)
    2.4 China CNS Specific Antisense Oligonucleotides Consumption Value (2018-2029)
    2.5 Europe CNS Specific Antisense Oligonucleotides Consumption Value (2018-2029)
    2.6 Japan CNS Specific Antisense Oligonucleotides Consumption Value (2018-2029)
    2.7 South Korea CNS Specific Antisense Oligonucleotides Consumption Value (2018-2029)
    2.8 ASEAN CNS Specific Antisense Oligonucleotides Consumption Value (2018-2029)
    2.9 India CNS Specific Antisense Oligonucleotides Consumption Value (2018-2029)

3 World CNS Specific Antisense Oligonucleotides Companies Competitive Analysis
    3.1 World CNS Specific Antisense Oligonucleotides Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global CNS Specific Antisense Oligonucleotides Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for CNS Specific Antisense Oligonucleotides in 2022
        3.2.3 Global Concentration Ratios (CR8) for CNS Specific Antisense Oligonucleotides in 2022
    3.3 CNS Specific Antisense Oligonucleotides Company Evaluation Quadrant
    3.4 CNS Specific Antisense Oligonucleotides Market: Overall Company Footprint Analysis
        3.4.1 CNS Specific Antisense Oligonucleotides Market: Region Footprint
        3.4.2 CNS Specific Antisense Oligonucleotides Market: Company Product Type Footprint
        3.4.3 CNS Specific Antisense Oligonucleotides Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: CNS Specific Antisense Oligonucleotides Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: CNS Specific Antisense Oligonucleotides Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: CNS Specific Antisense Oligonucleotides Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: CNS Specific Antisense Oligonucleotides Consumption Value Comparison
        4.2.1 United States VS China: CNS Specific Antisense Oligonucleotides Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: CNS Specific Antisense Oligonucleotides Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based CNS Specific Antisense Oligonucleotides Companies and Market Share, 2018-2023
        4.3.1 United States Based CNS Specific Antisense Oligonucleotides Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies CNS Specific Antisense Oligonucleotides Revenue, (2018-2023)
    4.4 China Based Companies CNS Specific Antisense Oligonucleotides Revenue and Market Share, 2018-2023
        4.4.1 China Based CNS Specific Antisense Oligonucleotides Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies CNS Specific Antisense Oligonucleotides Revenue, (2018-2023)
    4.5 Rest of World Based CNS Specific Antisense Oligonucleotides Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based CNS Specific Antisense Oligonucleotides Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies CNS Specific Antisense Oligonucleotides Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World CNS Specific Antisense Oligonucleotides Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Polyneuropathy Treatment
        5.2.2 Spinal Muscular Atrophy (SMA) Treatment
        5.2.3 Huntington’s Disease Treatment
    5.3 Market Segment by Type
        5.3.1 World CNS Specific Antisense Oligonucleotides Market Size by Type (2018-2023)
        5.3.2 World CNS Specific Antisense Oligonucleotides Market Size by Type (2024-2029)
        5.3.3 World CNS Specific Antisense Oligonucleotides Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World CNS Specific Antisense Oligonucleotides Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospital Pharmacies
        6.2.2 Retail Pharmacies
        6.2.3 Online Pharmacies
    6.3 Market Segment by Application
        6.3.1 World CNS Specific Antisense Oligonucleotides Market Size by Application (2018-2023)
        6.3.2 World CNS Specific Antisense Oligonucleotides Market Size by Application (2024-2029)
        6.3.3 World CNS Specific Antisense Oligonucleotides Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Akcea Therapeutics, Inc.
        7.1.1 Akcea Therapeutics, Inc. Details
        7.1.2 Akcea Therapeutics, Inc. Major Business
        7.1.3 Akcea Therapeutics, Inc. CNS Specific Antisense Oligonucleotides Product and Services
        7.1.4 Akcea Therapeutics, Inc. CNS Specific Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Akcea Therapeutics, Inc. Recent Developments/Updates
        7.1.6 Akcea Therapeutics, Inc. Competitive Strengths & Weaknesses
    7.2 Ionis Pharmaceuticals Inc.
        7.2.1 Ionis Pharmaceuticals Inc. Details
        7.2.2 Ionis Pharmaceuticals Inc. Major Business
        7.2.3 Ionis Pharmaceuticals Inc. CNS Specific Antisense Oligonucleotides Product and Services
        7.2.4 Ionis Pharmaceuticals Inc. CNS Specific Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Ionis Pharmaceuticals Inc. Recent Developments/Updates
        7.2.6 Ionis Pharmaceuticals Inc. Competitive Strengths & Weaknesses
    7.3 Biogen Inc.
        7.3.1 Biogen Inc. Details
        7.3.2 Biogen Inc. Major Business
        7.3.3 Biogen Inc. CNS Specific Antisense Oligonucleotides Product and Services
        7.3.4 Biogen Inc. CNS Specific Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Biogen Inc. Recent Developments/Updates
        7.3.6 Biogen Inc. Competitive Strengths & Weaknesses
    7.4 Sarepta Therapeutics
        7.4.1 Sarepta Therapeutics Details
        7.4.2 Sarepta Therapeutics Major Business
        7.4.3 Sarepta Therapeutics CNS Specific Antisense Oligonucleotides Product and Services
        7.4.4 Sarepta Therapeutics CNS Specific Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Sarepta Therapeutics Recent Developments/Updates
        7.4.6 Sarepta Therapeutics Competitive Strengths & Weaknesses
    7.5 Wave Life Sciences Ltd.
        7.5.1 Wave Life Sciences Ltd. Details
        7.5.2 Wave Life Sciences Ltd. Major Business
        7.5.3 Wave Life Sciences Ltd. CNS Specific Antisense Oligonucleotides Product and Services
        7.5.4 Wave Life Sciences Ltd. CNS Specific Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Wave Life Sciences Ltd. Recent Developments/Updates
        7.5.6 Wave Life Sciences Ltd. Competitive Strengths & Weaknesses
    7.6 Dynacure
        7.6.1 Dynacure Details
        7.6.2 Dynacure Major Business
        7.6.3 Dynacure CNS Specific Antisense Oligonucleotides Product and Services
        7.6.4 Dynacure CNS Specific Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Dynacure Recent Developments/Updates
        7.6.6 Dynacure Competitive Strengths & Weaknesses
    7.7 ProQR Therapeutics N.V.
        7.7.1 ProQR Therapeutics N.V. Details
        7.7.2 ProQR Therapeutics N.V. Major Business
        7.7.3 ProQR Therapeutics N.V. CNS Specific Antisense Oligonucleotides Product and Services
        7.7.4 ProQR Therapeutics N.V. CNS Specific Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 ProQR Therapeutics N.V. Recent Developments/Updates
        7.7.6 ProQR Therapeutics N.V. Competitive Strengths & Weaknesses
    7.8 Stroke Therapeutic Inc.
        7.8.1 Stroke Therapeutic Inc. Details
        7.8.2 Stroke Therapeutic Inc. Major Business
        7.8.3 Stroke Therapeutic Inc. CNS Specific Antisense Oligonucleotides Product and Services
        7.8.4 Stroke Therapeutic Inc. CNS Specific Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Stroke Therapeutic Inc. Recent Developments/Updates
        7.8.6 Stroke Therapeutic Inc. Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 CNS Specific Antisense Oligonucleotides Industry Chain
    8.2 CNS Specific Antisense Oligonucleotides Upstream Analysis
    8.3 CNS Specific Antisense Oligonucleotides Midstream Analysis
    8.4 CNS Specific Antisense Oligonucleotides Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World CNS Specific Antisense Oligonucleotides Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World CNS Specific Antisense Oligonucleotides Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World CNS Specific Antisense Oligonucleotides Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World CNS Specific Antisense Oligonucleotides Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World CNS Specific Antisense Oligonucleotides Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World CNS Specific Antisense Oligonucleotides Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World CNS Specific Antisense Oligonucleotides Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World CNS Specific Antisense Oligonucleotides Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World CNS Specific Antisense Oligonucleotides Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key CNS Specific Antisense Oligonucleotides Players in 2022
    Table 12. World CNS Specific Antisense Oligonucleotides Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global CNS Specific Antisense Oligonucleotides Company Evaluation Quadrant
    Table 14. Head Office of Key CNS Specific Antisense Oligonucleotides Player
    Table 15. CNS Specific Antisense Oligonucleotides Market: Company Product Type Footprint
    Table 16. CNS Specific Antisense Oligonucleotides Market: Company Product Application Footprint
    Table 17. CNS Specific Antisense Oligonucleotides Mergers & Acquisitions Activity
    Table 18. United States VS China CNS Specific Antisense Oligonucleotides Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China CNS Specific Antisense Oligonucleotides Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based CNS Specific Antisense Oligonucleotides Companies, Headquarters (States, Country)
    Table 21. United States Based Companies CNS Specific Antisense Oligonucleotides Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies CNS Specific Antisense Oligonucleotides Revenue Market Share (2018-2023)
    Table 23. China Based CNS Specific Antisense Oligonucleotides Companies, Headquarters (Province, Country)
    Table 24. China Based Companies CNS Specific Antisense Oligonucleotides Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies CNS Specific Antisense Oligonucleotides Revenue Market Share (2018-2023)
    Table 26. Rest of World Based CNS Specific Antisense Oligonucleotides Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies CNS Specific Antisense Oligonucleotides Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies CNS Specific Antisense Oligonucleotides Revenue Market Share (2018-2023)
    Table 29. World CNS Specific Antisense Oligonucleotides Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World CNS Specific Antisense Oligonucleotides Market Size by Type (2018-2023) & (USD Million)
    Table 31. World CNS Specific Antisense Oligonucleotides Market Size by Type (2024-2029) & (USD Million)
    Table 32. World CNS Specific Antisense Oligonucleotides Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World CNS Specific Antisense Oligonucleotides Market Size by Application (2018-2023) & (USD Million)
    Table 34. World CNS Specific Antisense Oligonucleotides Market Size by Application (2024-2029) & (USD Million)
    Table 35. Akcea Therapeutics, Inc. Basic Information, Area Served and Competitors
    Table 36. Akcea Therapeutics, Inc. Major Business
    Table 37. Akcea Therapeutics, Inc. CNS Specific Antisense Oligonucleotides Product and Services
    Table 38. Akcea Therapeutics, Inc. CNS Specific Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Akcea Therapeutics, Inc. Recent Developments/Updates
    Table 40. Akcea Therapeutics, Inc. Competitive Strengths & Weaknesses
    Table 41. Ionis Pharmaceuticals Inc. Basic Information, Area Served and Competitors
    Table 42. Ionis Pharmaceuticals Inc. Major Business
    Table 43. Ionis Pharmaceuticals Inc. CNS Specific Antisense Oligonucleotides Product and Services
    Table 44. Ionis Pharmaceuticals Inc. CNS Specific Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Ionis Pharmaceuticals Inc. Recent Developments/Updates
    Table 46. Ionis Pharmaceuticals Inc. Competitive Strengths & Weaknesses
    Table 47. Biogen Inc. Basic Information, Area Served and Competitors
    Table 48. Biogen Inc. Major Business
    Table 49. Biogen Inc. CNS Specific Antisense Oligonucleotides Product and Services
    Table 50. Biogen Inc. CNS Specific Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Biogen Inc. Recent Developments/Updates
    Table 52. Biogen Inc. Competitive Strengths & Weaknesses
    Table 53. Sarepta Therapeutics Basic Information, Area Served and Competitors
    Table 54. Sarepta Therapeutics Major Business
    Table 55. Sarepta Therapeutics CNS Specific Antisense Oligonucleotides Product and Services
    Table 56. Sarepta Therapeutics CNS Specific Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Sarepta Therapeutics Recent Developments/Updates
    Table 58. Sarepta Therapeutics Competitive Strengths & Weaknesses
    Table 59. Wave Life Sciences Ltd. Basic Information, Area Served and Competitors
    Table 60. Wave Life Sciences Ltd. Major Business
    Table 61. Wave Life Sciences Ltd. CNS Specific Antisense Oligonucleotides Product and Services
    Table 62. Wave Life Sciences Ltd. CNS Specific Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Wave Life Sciences Ltd. Recent Developments/Updates
    Table 64. Wave Life Sciences Ltd. Competitive Strengths & Weaknesses
    Table 65. Dynacure Basic Information, Area Served and Competitors
    Table 66. Dynacure Major Business
    Table 67. Dynacure CNS Specific Antisense Oligonucleotides Product and Services
    Table 68. Dynacure CNS Specific Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Dynacure Recent Developments/Updates
    Table 70. Dynacure Competitive Strengths & Weaknesses
    Table 71. ProQR Therapeutics N.V. Basic Information, Area Served and Competitors
    Table 72. ProQR Therapeutics N.V. Major Business
    Table 73. ProQR Therapeutics N.V. CNS Specific Antisense Oligonucleotides Product and Services
    Table 74. ProQR Therapeutics N.V. CNS Specific Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. ProQR Therapeutics N.V. Recent Developments/Updates
    Table 76. Stroke Therapeutic Inc. Basic Information, Area Served and Competitors
    Table 77. Stroke Therapeutic Inc. Major Business
    Table 78. Stroke Therapeutic Inc. CNS Specific Antisense Oligonucleotides Product and Services
    Table 79. Stroke Therapeutic Inc. CNS Specific Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 80. Global Key Players of CNS Specific Antisense Oligonucleotides Upstream (Raw Materials)
    Table 81. CNS Specific Antisense Oligonucleotides Typical Customers
List of Figure
    Figure 1. CNS Specific Antisense Oligonucleotides Picture
    Figure 2. World CNS Specific Antisense Oligonucleotides Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World CNS Specific Antisense Oligonucleotides Total Market Size (2018-2029) & (USD Million)
    Figure 4. World CNS Specific Antisense Oligonucleotides Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World CNS Specific Antisense Oligonucleotides Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company CNS Specific Antisense Oligonucleotides Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company CNS Specific Antisense Oligonucleotides Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company CNS Specific Antisense Oligonucleotides Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company CNS Specific Antisense Oligonucleotides Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company CNS Specific Antisense Oligonucleotides Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company CNS Specific Antisense Oligonucleotides Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company CNS Specific Antisense Oligonucleotides Revenue (2018-2029) & (USD Million)
    Figure 13. CNS Specific Antisense Oligonucleotides Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World CNS Specific Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 16. World CNS Specific Antisense Oligonucleotides Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States CNS Specific Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 18. China CNS Specific Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe CNS Specific Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan CNS Specific Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea CNS Specific Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN CNS Specific Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 23. India CNS Specific Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of CNS Specific Antisense Oligonucleotides by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for CNS Specific Antisense Oligonucleotides Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for CNS Specific Antisense Oligonucleotides Markets in 2022
    Figure 27. United States VS China: CNS Specific Antisense Oligonucleotides Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: CNS Specific Antisense Oligonucleotides Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World CNS Specific Antisense Oligonucleotides Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World CNS Specific Antisense Oligonucleotides Market Size Market Share by Type in 2022
    Figure 31. Polyneuropathy Treatment
    Figure 32. Spinal Muscular Atrophy (SMA) Treatment
    Figure 33. Huntington’s Disease Treatment
    Figure 34. World CNS Specific Antisense Oligonucleotides Market Size Market Share by Type (2018-2029)
    Figure 35. World CNS Specific Antisense Oligonucleotides Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 36. World CNS Specific Antisense Oligonucleotides Market Size Market Share by Application in 2022
    Figure 37. Hospital Pharmacies
    Figure 38. Retail Pharmacies
    Figure 39. Online Pharmacies
    Figure 40. CNS Specific Antisense Oligonucleotides Industrial Chain
    Figure 41. Methodology
    Figure 42. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Akcea Therapeutics, Inc.
Ionis Pharmaceuticals Inc.
Biogen Inc.
Sarepta Therapeutics
Wave Life Sciences Ltd.
Dynacure
ProQR Therapeutics N.V.
Stroke Therapeutic Inc.

Related Reports

Global CNS Specific Antisense Oligonucleotides Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global CNS Specific Antisense Oligonucleotides Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Service & Software

According to our (Global Info Research) latest study, the global CNS Specific Antisense Oligonucleotides market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

CNS Specific Antisense Oligonucleotides

soil fertility

Image High Dynamic

Building Energy Modeling

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>